Cargando…
Independent Prognostic Value of Intratumoral Heterogeneity and Immune Response Features by Automated Digital Immunohistochemistry Analysis in Early Hormone Receptor-Positive Breast Carcinoma
Immunohistochemistry (IHC) for ER, PR, HER2, and Ki67 is used to predict outcome and therapy response in breast cancer patients. The current IHC assessment, visual or digital, is based mostly on global biomarker expression levels in the tissue sample. In our study, we explored the prognostic value o...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7308549/ https://www.ncbi.nlm.nih.gov/pubmed/32612954 http://dx.doi.org/10.3389/fonc.2020.00950 |
_version_ | 1783549013956493312 |
---|---|
author | Zilenaite, Dovile Rasmusson, Allan Augulis, Renaldas Besusparis, Justinas Laurinaviciene, Aida Plancoulaine, Benoit Ostapenko, Valerijus Laurinavicius, Arvydas |
author_facet | Zilenaite, Dovile Rasmusson, Allan Augulis, Renaldas Besusparis, Justinas Laurinaviciene, Aida Plancoulaine, Benoit Ostapenko, Valerijus Laurinavicius, Arvydas |
author_sort | Zilenaite, Dovile |
collection | PubMed |
description | Immunohistochemistry (IHC) for ER, PR, HER2, and Ki67 is used to predict outcome and therapy response in breast cancer patients. The current IHC assessment, visual or digital, is based mostly on global biomarker expression levels in the tissue sample. In our study, we explored the prognostic value of digital image analysis of conventional breast cancer IHC biomarkers supplemented with their intratumoral heterogeneity and tissue immune response indicators. Surgically excised tumor samples from 101 female patients with hormone receptor-positive breast cancer (HRBC) were stained for ER, PR, HER2, Ki67, SATB1, CD8, and scanned at 20x. Digital image analysis was performed using the HALO™ platform. Subsequently, hexagonal tiling was used to compute intratumoral heterogeneity indicators for ER, PR and Ki67 expression. Multiple Cox regression analysis revealed three independent predictors of the patient's overall survival: Haralick's texture entropy of PR (HR = 0.19, p = 0.0005), Ki67 Ashman's D bimodality (HR = 3.0, p = 0.01), and CD8+SATB1+ cell density in tumor tissue (HR = 0.32, p = 0.02). Remarkably, the PR and Ki67 intratumoral heterogeneity indicators were prognostically more informative than the rates of their expression. In particular, a distinct non-linear relationship between the rate of PR expression and its intratumoral heterogeneity was observed and revealed a non-linear prognostic effect of PR expression. The independent prognostic significance of CD8+SATB1+ cells infiltrating the tumor could indicate their role in anti-tumor immunity. In conclusion, we suggest that prognostic modeling, based entirely on the computational image-based IHC biomarkers, is possible in HRBC patients. The intratumoral heterogeneity and immune response indicators outperformed both conventional breast cancer IHC and clinicopathological variables while markedly increasing the power of the model. |
format | Online Article Text |
id | pubmed-7308549 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-73085492020-06-30 Independent Prognostic Value of Intratumoral Heterogeneity and Immune Response Features by Automated Digital Immunohistochemistry Analysis in Early Hormone Receptor-Positive Breast Carcinoma Zilenaite, Dovile Rasmusson, Allan Augulis, Renaldas Besusparis, Justinas Laurinaviciene, Aida Plancoulaine, Benoit Ostapenko, Valerijus Laurinavicius, Arvydas Front Oncol Oncology Immunohistochemistry (IHC) for ER, PR, HER2, and Ki67 is used to predict outcome and therapy response in breast cancer patients. The current IHC assessment, visual or digital, is based mostly on global biomarker expression levels in the tissue sample. In our study, we explored the prognostic value of digital image analysis of conventional breast cancer IHC biomarkers supplemented with their intratumoral heterogeneity and tissue immune response indicators. Surgically excised tumor samples from 101 female patients with hormone receptor-positive breast cancer (HRBC) were stained for ER, PR, HER2, Ki67, SATB1, CD8, and scanned at 20x. Digital image analysis was performed using the HALO™ platform. Subsequently, hexagonal tiling was used to compute intratumoral heterogeneity indicators for ER, PR and Ki67 expression. Multiple Cox regression analysis revealed three independent predictors of the patient's overall survival: Haralick's texture entropy of PR (HR = 0.19, p = 0.0005), Ki67 Ashman's D bimodality (HR = 3.0, p = 0.01), and CD8+SATB1+ cell density in tumor tissue (HR = 0.32, p = 0.02). Remarkably, the PR and Ki67 intratumoral heterogeneity indicators were prognostically more informative than the rates of their expression. In particular, a distinct non-linear relationship between the rate of PR expression and its intratumoral heterogeneity was observed and revealed a non-linear prognostic effect of PR expression. The independent prognostic significance of CD8+SATB1+ cells infiltrating the tumor could indicate their role in anti-tumor immunity. In conclusion, we suggest that prognostic modeling, based entirely on the computational image-based IHC biomarkers, is possible in HRBC patients. The intratumoral heterogeneity and immune response indicators outperformed both conventional breast cancer IHC and clinicopathological variables while markedly increasing the power of the model. Frontiers Media S.A. 2020-06-16 /pmc/articles/PMC7308549/ /pubmed/32612954 http://dx.doi.org/10.3389/fonc.2020.00950 Text en Copyright © 2020 Zilenaite, Rasmusson, Augulis, Besusparis, Laurinaviciene, Plancoulaine, Ostapenko and Laurinavicius. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Zilenaite, Dovile Rasmusson, Allan Augulis, Renaldas Besusparis, Justinas Laurinaviciene, Aida Plancoulaine, Benoit Ostapenko, Valerijus Laurinavicius, Arvydas Independent Prognostic Value of Intratumoral Heterogeneity and Immune Response Features by Automated Digital Immunohistochemistry Analysis in Early Hormone Receptor-Positive Breast Carcinoma |
title | Independent Prognostic Value of Intratumoral Heterogeneity and Immune Response Features by Automated Digital Immunohistochemistry Analysis in Early Hormone Receptor-Positive Breast Carcinoma |
title_full | Independent Prognostic Value of Intratumoral Heterogeneity and Immune Response Features by Automated Digital Immunohistochemistry Analysis in Early Hormone Receptor-Positive Breast Carcinoma |
title_fullStr | Independent Prognostic Value of Intratumoral Heterogeneity and Immune Response Features by Automated Digital Immunohistochemistry Analysis in Early Hormone Receptor-Positive Breast Carcinoma |
title_full_unstemmed | Independent Prognostic Value of Intratumoral Heterogeneity and Immune Response Features by Automated Digital Immunohistochemistry Analysis in Early Hormone Receptor-Positive Breast Carcinoma |
title_short | Independent Prognostic Value of Intratumoral Heterogeneity and Immune Response Features by Automated Digital Immunohistochemistry Analysis in Early Hormone Receptor-Positive Breast Carcinoma |
title_sort | independent prognostic value of intratumoral heterogeneity and immune response features by automated digital immunohistochemistry analysis in early hormone receptor-positive breast carcinoma |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7308549/ https://www.ncbi.nlm.nih.gov/pubmed/32612954 http://dx.doi.org/10.3389/fonc.2020.00950 |
work_keys_str_mv | AT zilenaitedovile independentprognosticvalueofintratumoralheterogeneityandimmuneresponsefeaturesbyautomateddigitalimmunohistochemistryanalysisinearlyhormonereceptorpositivebreastcarcinoma AT rasmussonallan independentprognosticvalueofintratumoralheterogeneityandimmuneresponsefeaturesbyautomateddigitalimmunohistochemistryanalysisinearlyhormonereceptorpositivebreastcarcinoma AT augulisrenaldas independentprognosticvalueofintratumoralheterogeneityandimmuneresponsefeaturesbyautomateddigitalimmunohistochemistryanalysisinearlyhormonereceptorpositivebreastcarcinoma AT besusparisjustinas independentprognosticvalueofintratumoralheterogeneityandimmuneresponsefeaturesbyautomateddigitalimmunohistochemistryanalysisinearlyhormonereceptorpositivebreastcarcinoma AT laurinavicieneaida independentprognosticvalueofintratumoralheterogeneityandimmuneresponsefeaturesbyautomateddigitalimmunohistochemistryanalysisinearlyhormonereceptorpositivebreastcarcinoma AT plancoulainebenoit independentprognosticvalueofintratumoralheterogeneityandimmuneresponsefeaturesbyautomateddigitalimmunohistochemistryanalysisinearlyhormonereceptorpositivebreastcarcinoma AT ostapenkovalerijus independentprognosticvalueofintratumoralheterogeneityandimmuneresponsefeaturesbyautomateddigitalimmunohistochemistryanalysisinearlyhormonereceptorpositivebreastcarcinoma AT laurinaviciusarvydas independentprognosticvalueofintratumoralheterogeneityandimmuneresponsefeaturesbyautomateddigitalimmunohistochemistryanalysisinearlyhormonereceptorpositivebreastcarcinoma |